Venuti, Michael

Jones Gordon H., Venuti Michael C., Young John M. US Patent No. 4,466,981 ... 

Asked what he thought the initial expectations for genomic data were, Dr Michael C. Venuti, former head of research at Arris (later Axys) Pharmaceuticals, and now CEO of BioSeek, put it wryly. I think everyone in biotech and pharma hoped that we would take out our secret decoder ring and there d be all kinds of things in there that would be obvious if we turned on our computers at the right time of day, he said. I think everyone eventually came to the realization that it s what everyone did with the information that matters, and it s still what anyone does with the information that matters. ... 

I asked Dr Michael Venuti how the pharmaceutical industry has been able to keep up profits in the face of fewer new products. Well, there s market penetration to increase the size of the market, he explained. One thing the pharmaceutical industry has done effectively is it s created markets. Twenty years ago there were no such markets as erectile dysfunction or restless leg syndrome. So they ve created markets where there is a treatable condition. ... 

---